Skip to main content
SpringerLink
Log in

The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14–22.

    Article  CAS  PubMed  Google Scholar 

  2. James C, Delhommeau F, Marzac C, Teyssandier I, Couédic J-P, Giraudier S et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia 2006; 20: 350–353.

    Article  CAS  PubMed  Google Scholar 

  3. Marková J, Průková D, Volková Z, Schwarz J . A new allelic discrimination assay using locked nucleic acid-modified nucleotides (LNA) probes for detection of JAK2 V617F mutation. Leuk Lymphoma 2007; 48: 636–639.

    Article  PubMed  Google Scholar 

  4. Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007; 356: 459–468.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lengfelder E, Hochhaus A, Kronawitter U, Höche D, Queisser W, Jahn-Eder M et al. Should a platelet limit of 600 × 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol 1998; 100: 15–23.

    Article  CAS  PubMed  Google Scholar 

  6. Michiels JJ, Thiele J . Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia). Int J Hematol 2002; 76: 133–145.

    Article  PubMed  Google Scholar 

  7. Schwarz J, Pytlík R, Doubek M, Brychtová Y, Dulíc̆ek P, Campr V et al. Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia. Semin Thromb Hemost 2006; 32: 231–245.

    Article  PubMed  Google Scholar 

  8. Thiele J, Kvasnicka HM, Orazi A . Bone marrow histopathology in myeloproliferative disorders—current diagnostic approach. Semin Hematol 2005; 42: 184–195.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Section, Institute of Hematology and Blood Transfusion, Prague, Czechia

    J Schwarz

  2. Department of Clinical Hematology, Masaryk University Faculty Hospital, Brno, Czechia

    M Penka

  3. Department of Internal Medicine-Hematooncology, Palacký University Faculty Hospital, Olomouc, Czechia

    K Indrák

  4. Department of Pediatrics, Palacký University Faculty Hospital, Olomouc, Czechia

    D Pospís̆ilová

  5. Ist Department of Internal Medicine, Charles University General Hospital, Prague, Czechia

    R Pytlík

  6. IInd Department of Internal Medicine-Clinical Hematology, Charles University, Faculty Hospital, Hradec Kr, á, lové, Czechia

    P Dulíc̆ek

  7. IInd Department of Internal Medicine-Hematooncology, Masaryk University Faculty Hospital, Brno, Czechia

    M Doubek

  8. Department of Pathology, Masaryk University Faculty Hospital, Brno, Czechia

    L Křen

  9. Institute of Pathological Anatomy, Faculty Hospital Motol, Charles University, Prague, Czechia

    V Campr

Authors
  1. J Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Penka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Indrák
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Pospís̆ilová
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Pytlík
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Dulíc̆ek
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Doubek
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L Křen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V Campr
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Czech MPD Working Group

Corresponding author

Correspondence to J Schwarz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwarz, J., Penka, M., Indrák, K. et al. The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group. Leukemia 22, 2118–2119 (2008). https://doi.org/10.1038/leu.2008.93

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.93

  • Springer Nature Limited

Search

Navigation